CYP2A6 and urinary bladder carcinoma: The amplification of the CYP2A6 gene in primary bladder cancers was also tested by qPCR which confirmed that CYP2A6 was amplified in one papillary tumor and five invasive tumors (copy number gain > +1), and the difference was statistically significant (p = 0.0085; Fig 4B).